User:ChrisMisu/Pharmacoeconomics

Article body
In the past 30 years, major pharmaceutical innovations have improved condition-related outcomes for six serious medical conditions:  ischemic heart disease, lung cancer, breast cancer, human immunodeficiency virus (HIV) infection, type 2 diabetes mellitus, and rheumatoid arthritis (RA).